Therapeutic indications: Zeyzelf® (rivastigmine) is a twice weekly transdermal patch indicated for the symptomatic treatment of mild to moderately severe Alzheimer’s dementia.

The Zeyzelf® patch should be replaced twice weekly on fixed days (after four and three days, respectively). To optimise adherence to the skin, an oval shaped adhesive cover is provided which is applied over the active patch.

Adverse events should be reported

Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/.

Adverse events should also be reported to Luye Pharma Ltd. at safety@luyepharma.co.uk.

Zeyzelf Double Packshot

Technical information

Active Ingredients: Rivastigmine
Therapeutic area: Neurology
Pharmaceutical Form: Transdermal Patch

Strengths, Pack size and Information

Description Strength Pack Size PIP Code
Zeyzelf® 4.6mg 8 patches 5401682
Zeyzelf® 9.5mg 8 patches 5401674